258 related articles for article (PubMed ID: 12727927)
21. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
[TBL] [Abstract][Full Text] [Related]
23. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW
J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395
[TBL] [Abstract][Full Text] [Related]
24. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
[TBL] [Abstract][Full Text] [Related]
25. Prevention of autoimmune type 1 diabetes via mucosal tolerance: is mucosal autoantigen administration as safe and effective as it should be?
Hänninen A
Scand J Immunol; 2000 Sep; 52(3):217-25. PubMed ID: 10972896
[TBL] [Abstract][Full Text] [Related]
26. Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin.
Griffin AC; Zhao W; Wegmann KW; Hickley WF
Am J Pathol; 1995 Sep; 147(3):845-57. PubMed ID: 7545875
[TBL] [Abstract][Full Text] [Related]
27. Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform.
Gottlieb P; Utz PJ; Robinson W; Steinman L
Clin Immunol; 2013 Dec; 149(3):297-306. PubMed ID: 24094739
[TBL] [Abstract][Full Text] [Related]
28. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.
Yoon JW; Yoon CS; Lim HW; Huang QQ; Kang Y; Pyun KH; Hirasawa K; Sherwin RS; Jun HS
Science; 1999 May; 284(5417):1183-7. PubMed ID: 10325232
[TBL] [Abstract][Full Text] [Related]
29. Primary Human and Rat β-Cells Release the Intracellular Autoantigens GAD65, IA-2, and Proinsulin in Exosomes Together With Cytokine-Induced Enhancers of Immunity.
Cianciaruso C; Phelps EA; Pasquier M; Hamelin R; Demurtas D; Alibashe Ahmed M; Piemonti L; Hirosue S; Swartz MA; De Palma M; Hubbell JA; Baekkeskov S
Diabetes; 2017 Feb; 66(2):460-473. PubMed ID: 27872147
[TBL] [Abstract][Full Text] [Related]
30. Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses.
Dénes B; Yu J; Fodor N; Takátsy Z; Fodor I; Langridge WH
Mol Biotechnol; 2006 Nov; 34(3):317-27. PubMed ID: 17284779
[TBL] [Abstract][Full Text] [Related]
31. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
32. Insulin as a primary autoantigen for type 1A diabetes.
Jasinski JM; Eisenbarth GS
Clin Dev Immunol; 2005 Sep; 12(3):181-6. PubMed ID: 16295523
[TBL] [Abstract][Full Text] [Related]
33. Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens.
Denes B; Krausova V; Fodor N; Timiryasova T; Henderson D; Hough J; Yu J; Fodor I; Langridge WH
J Immunother; 2005; 28(5):438-48. PubMed ID: 16113600
[TBL] [Abstract][Full Text] [Related]
34. Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.
Michels AW; Landry LG; McDaniel KA; Yu L; Campbell-Thompson M; Kwok WW; Jones KL; Gottlieb PA; Kappler JW; Tang Q; Roep BO; Atkinson MA; Mathews CE; Nakayama M
Diabetes; 2017 Mar; 66(3):722-734. PubMed ID: 27920090
[TBL] [Abstract][Full Text] [Related]
35. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
[TBL] [Abstract][Full Text] [Related]
36. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice.
Beilhack GF; Scheffold YC; Weissman IL; Taylor C; Jerabek L; Burge MJ; Masek MA; Shizuru JA
Diabetes; 2003 Jan; 52(1):59-68. PubMed ID: 12502494
[TBL] [Abstract][Full Text] [Related]
37. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes.
Jaeckel E; Lipes MA; von Boehmer H
Nat Immunol; 2004 Oct; 5(10):1028-35. PubMed ID: 15378058
[TBL] [Abstract][Full Text] [Related]
38. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
39. The prospect of vaccination to prevent type 1 diabetes.
Harrison LC
Hum Vaccin; 2005; 1(4):143-50. PubMed ID: 17012869
[TBL] [Abstract][Full Text] [Related]
40. A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice.
Gurr W; Yavari R; Wen L; Shaw M; Mora C; Christa L; Sherwin RS
Diabetes; 2002 Feb; 51(2):339-46. PubMed ID: 11812740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
